ArticleBiotechnology letters2026
Regulation of N-terminal cleavage and splicing in mini-Ter DnaE-3 intein by E23G and R50Q mutations.
Article in Biotechnology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundAs a member of the DnaE intein family, Ter DnaE-3 (TE3) is limited by a relatively low splicing rate, significant undesired N-terminal cleavage reactions, and dependence on native exteins.
methodsBuilding on eight previously identified mutation sites from directed evolution, we employed site-directed mutagenesis to systematically investigate how these residues regulate wild-type mini-TE3 splicing and cleavage activities across various expression systems.
resultsIn the pKH kanamycin resistance system, the E23G mutation reduces N-cleavage propensity, which may be attributed to reduced steric hindrance and enhanced structural flexibility. Conversely, in both pKH and pMST systems, the R50Q mutation increases the accumulation of N-terminal cleavage products, suggesting that intein catalysis may be influenced by a distributed regulatory network rather than by isolated residues.
conclusionThese results suggest that the catalytic behavior of TE3 is governed not only by conserved catalytic cores and adjacent extein sequences but also by distal residues that modulate the intein structure. The discovery that R50Q enhances N-terminal cleavage provides a valuable tool for future protein engineering, particularly for optimizing intein-based protein purification and expressed protein ligation (EPL) technologies.
Indexed as
Identifiers
42616204What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.